Effect | Decrease |
Trial Design | Double blind |
Trial Length | 6+ Months |
Number of Subjects | 101 |
Sex | Both Genders |
Age Range | 18-29, 30-44, 45-64 |
Body Types | Average |
101 patients suffering from non-psychotic anxiety using Kava (WS 1490 extract) over 25 weeks noted statistically significant benefits starting after week 8.